Low bone mineral density in institutionalized patients with HIV and psychiatric co-morbidity

Area of Science:

• Medical Science
• Bone Health Research
• HIV/AIDS Studies

Background:

• Osteoporosis is a known complication in HIV-infected individuals and those with psychiatric conditions.
• No studies have assessed bone mineral density (BMD) in institutionalized HIV patients with co-occurring psychiatric disorders.
• Antiretroviral therapy and antipsychotic medications may impact bone health.

Purpose of the Study:

• To evaluate bone mineral density (BMD) in institutionalized HIV patients with psychiatric co-morbidity.
• To compare BMD between HIV patients with psychiatric disorders and healthy controls.
• To identify potential co-factors influencing bone health in this population.

Main Methods:

• A case-control study involving 51 subjects.
• 17 HIV patients (males or pre-menopausal females) on long-term antipsychotic and antiretroviral therapy with psychiatric co-morbidity.
• 34 age- and sex-matched healthy control subjects without HIV infection.

Main Results:

• The HIV group exhibited significantly higher rates of pathological T-scores (71%) compared to controls (9%, p<0.001).
• This indicates substantially lower bone mineral density in HIV patients with psychiatric co-morbidity.
• The findings suggest a significant difference in bone health between the groups.

Conclusions:

• Chronic mental illness may be a significant co-factor affecting bone mineral density in HIV patients.
• Institutionalized HIV patients with psychiatric co-morbidity are at higher risk for osteoporosis.
• Fracture risk assessment is crucial for this patient population.